BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

RNA vaccines have been a long time coming, but were only approved after covid-19 emerged, marking the beginning of a new way ...

Pfizer Inc. defeated a lawsuit from Texas Attorney General Ken Paxton that alleged the pharmaceutical giant misrepresented ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 ...

Vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public.

The BNT162b2 XBB vaccine shows 68% effectiveness in children aged 5-11 and 63% in those aged 12-17 against severe COVID-19 outcomes. The study involved 15,233 children, with a diverse demographic ...

The timeframe for people injured by COVID-19 "countermeasures," such ... Some are skeptical of the vaccine's effectiveness and others believe its contents produce irreparable side effects and ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.